Endocrinology 1 - Thyroid and Pituitary Flashcards
What hormones stimulate the TSHR?
TSH and b-HCG
Where is iodine taken up in the thyroid cell?
Via the NIS transporter (also transports Tc99)
What inhibits TPO?
PTU, carbimazole, goitrogens, iodine - prevents trafficking of Tg+T4/3 into the colliod.
What markers are increased in thyrotoxicosis?
Osteocalcin Urine pyridinium collagen cross links ALP Atrial natriuretic hormone SHBG Ferritin vWF
What markers are decreased in thyrotoxicosis?
LDL cholesterol
Lp(a)
What markers are increased in hypothyroidism?
CK (MM) LDL Prolactin Lp(a) Norepinephrine
What markers are decreased in hypothyroidism?
Vasopressin
What receptor antibodies are elevated in Grave’s disease?
TSHR-Ab 80-95%
hTgAb 50-70%
hTPOAb 50-80%
What receptor antibodies are elevated in autoimmune thyroiditis?
TSHR-Ab 10-20%
hTgAb 80-90%
hTOPAb 90-100%
What is the lifetime risk of grave’s disease?
2.5% in women, 0.25% in men
What is the aetiology of grave’s disease?
T-cell autoimmune process in thyroid - leads to TSHrAb production.
Associated with FHx of AI thyroid disease
Recent iodine exposure (e.g. contrast)
Post partum
What are clinical feat of grave’s disease?
Thyrotoxicosis
Diffuse goitre
eye signs
pretibial myxedema
How is the Dx of grave’s disease made?
confirm with TSHrAb or Tc99 scan
What is the management of Grave’s?
Control symptoms with b-blockade
Control hyperthyroidism with either carbimazole or PTU.
SEs include rash, altered LFTs, neutropenia, pANCA vasculitis.
I-131 usually safe, but caution in younger women or those with significant eye disease - successful Tx = hypothyroidism.
Surgery carries a risk of parathyroid injury, and may recur in remnant.
What are features of PTU?
Short half life (bd or tds dosing) Blocks conversion from T4 to T4 (preferred in T3 toxicosis) Fulminant inflammatory hepatitis rarely Safer than carbimazole in T1 of preg. enters breast milk but safe if
What are features of Carbimazole?
Daily dosing no effect on peripheral deiodinase can cause non-threatening cholestasis increased risk of aplasia cutis, omphalocoele and other birth defects enters breast milk, but safe if
What is the rationale of thionamide therapy of Graves?
Can titrate or block/replace.
12-18 months of treatment, with 50% remission rate.
Most relapses occur within 6 months of therapy
What are factors which favour long-term remission following anti-thyroid therapy?
T3 toxicosis Small goiter Decrease in goiter size during therapy Normal thyroid function tests and normal TSH Negative test for TSHr antibodiy
What are features of grave’s ophthalmopathy?
Can be independent of thyrotoxicosis
Can by asymmetrical
Smoking, iatrogenic hypothyroidism and I131 therapy are established risk factors for progression.
What are treatment options for grave’s ophthalmopathy?
may require referral to ophthalmolgist - pulse Iv steroid and radiotherapy in acute phase, surgical debulking in chronic phase.
What is the mechanism of grave’s ophthalmopathy?
TSH binds g-protein coupled TSH receptor.
increased cAMP and mTOR, also via IGF-1 receptor.
Leads to adipogenesis and hyaluronic acid synthesis - expanded orbital muscles and adipose tissue.
What medication is shown to improve orbitopathy in grave’s disease?
Selenium 100mcg bd improves orbitopathy in these patients. large proportion have selenium deficiency.
What is the cause of periodic paralysis in grave’s disease?
caused by transient severe hypokalemia, often following high CHO meal or exercise.
Usually only in asian people
only during thyrotoxic phase of illness
What are features of toxic nodule/MNG?
Usual presentation is of thyrotoxicosis, often isolated T3 toxicosis.
Often due to activating mutation (somatic) of TSHr
Treat with I131 or PTU/CBZ
Rarely malignant
Dx requires Tc99 scan.